The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
Open accessAbstract
Unlabelled We conducted a double-blind, placebo-controlled, crossover study evaluating the analgesic efficacy of vaporized cannabis in subjects, the majority of whom were experiencing neuropathic pain despite traditional treatment. Thirty-nine patients with central and peripheral neuropathic pain underwent a standardized procedure for inhaling medium-dose (3.53%), low-dose (1.29%), or placebo cannabis with the primary outcome being visual analog scale pain intensity. Psychoactive side effects and neuropsychological performance were also evaluated. Mixed-effects regression models demonstrated an analgesic response to vaporized cannabis. There was no significant difference between the 2 active dose groups' results (P > .7). The number needed to treat (NNT) to achieve 30% pain reduction was 3.2 for placebo versus low-dose, 2.9 for placebo versus medium-dose, and 25 for medium- versus low-dose. As these NNTs are comparable to those of traditional neuropathic pain medications, cannabis has analgesic efficacy with the low dose being as effective a pain reliever as the medium dose. Psychoactive effects were minimal and well tolerated, and neuropsychological effects were of limited duration and readily reversible within 1 to 2 hours. Vaporized cannabis, even at low doses, may present an effective option for patients with treatment-resistant neuropathic pain.Perspective The analgesia obtained from a low dose of delta-9-tetrahydrocannabinol (1.29%) in patients, most of whom were experiencing neuropathic pain despite conventional treatments, is a clinically significant outcome. In general, the effect sizes on cognitive testing were consistent with this minimal dose. As a result, one might not anticipate a significant impact on daily functioning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In neuropathic pain, cannabis containing both a lower dose (1.29 % THC) and higher dose (3.53 % THC) delivered by vaporizer demonstrated a significant analgesic response (Wilsey et al, 2013).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Wilsey et al, 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,528
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Berti, A. (1992) · Neuropsychologia · doi:10.1016/0028-3932(92)90076-x · Cited by 4,190
Harrison’s Principles of Internal Medicine
Malani, P. (2012) · JAMA · doi:10.1001/jama.308.17.1813-b · Cited by 2,047
Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage
Costigan, M., Scholz, J., & Woolf, C. J. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135531 · Cited by 2,025
Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998) · The Clinical Neuropsychologist · doi:10.1076/clin.12.1.43.1726 · Cited by 1,597
Pharmacokinetics and Pharmacodynamics of Cannabinoids
Grotenhermen, F. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00003 · Cited by 1,514
Dworkin, R. H., O'connor, A., Audette, J. F., Baron, R., Gourlay, G. K., Haanpää, M. L., Kent, J. L., Krane, E. J., Lebel, A., Levy, R. M., et al. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0649 · Cited by 1,342
International Association for the Study of Pain
Breivik, H. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00465-7 · Cited by 1,222
Flagged first, then by citations
2 of the 64 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Beaver, 1997, Workshop on the Medical Utility of Marijuana
- Gieringer, 1996, Marijuana research: Waterpipe study, Multidisciplinary Association for Psychedelic Studies Bulletin, 6, 59
Cited by
Sorted by citations
Items 201–300 of 313
Social work and medical students' perspectives on the use of cannabis as a medical intervention
Cogswell, J. B., & Harris, S. (2015) · John Spoor Broome Library Institutional Repository (California State University) · Cited by 5
Clinical Application of Cannabis Vaporization: Examining Safety and Best Practices
MacCallum, C. A., Lo, L. A., & Boivin, M. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0219 · Cited by 4
Evolution of the substance use landscape: Implications for contingency management
Goodwin, S. R., Kirby, K. C., & Raiff, B. R. (2024) · Journal of Applied Behavior Analysis · doi:10.1002/jaba.2911 · Cited by 4
The Medical Use of Marijuana: Issues and Indications
Horowitz, S. (2014) · Alternative and Complementary Therapies · doi:10.1089/act.2014.20601 · Cited by 4
Büntzel, J., Micke, O., & Büntzel, J. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03415-3 · Cited by 4
An answered call for aid? Cannabinoid clinical framework for the opioid epidemic
Hammaker, K., Weathington, N. M., Maroon, J. C., Tang, L. W., Donohue, B., Yehuda, R., Ford, K. M., Figura, M., Kelmendi, B., Tan, B., et al. (2023) · Harm Reduction Journal · doi:10.1186/s12954-023-00842-6 · Cited by 4
Cannabinoid-Related Adverse Events and Impairment
MacCallum, C. A., de Freitas, L., Lo, L. A., Eadie, L., & Brubacher, J. R. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_36 · Cited by 4
Marijuana for Pain Relief: Don't Jump to Conclusions
Stacey, B. R., & Moller, J. L. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.07.002 · Cited by 4
Wallace, M. S., & Ware, M. A. (2015) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000217 · Cited by 4
Korczeniewska, O. A., France, K., Khan, J., Greenberg, M. S., Benoliel, R., & Eliav, E. (2021) · Wiley eBooks · doi:10.1002/9781119597797.ch11 · Cited by 4
Machine-learning of medical cannabis chemical profiles reveals analgesia beyond placebo expectations
Hatav, A., Vysotski, Y., Shapira, A., Procaccia, S., Meiri, D., & Aran, D. (2025) · Communications Medicine · doi:10.1038/s43856-025-00996-3 · Cited by 3
Weiss, M. C., Giaddui, M., Kjelstrom, S., Gary, J. B., Ward, S. J., Burrell, J. A., DiGuilio, K. M., Bidas, G., Erebor, E., Meske, S. W., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1590168 · Cited by 3
Analysis of elemental impurities in cannabis following vaporization
Wang, Q., Öktem, B., Wu, C. G., Twaddle, N. C., & Taylor, C. L. (2023) · Talanta Open · doi:10.1016/j.talo.2023.100281 · Cited by 3
Aragon, F., Lozada, M., Bigatti, G., González‐José, R., Kochen, S. S., & McCarthy, I. (2025) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2025.2517778 · Cited by 3
Faraone, N., Hillier, N. K., & McSweeney, M. B. (2020) · Journal of Sensory Studies · doi:10.1111/joss.12624 · Cited by 3
Cannabinoids for the Treatment of Chronic Pain: A Critical Review of Randomized Controlled Trials
Hassan, S. I. (2018) · Journal of Pain Management & Medicine · doi:10.35248/2684-1320.18.4.131 · Cited by 4
Hulland, O., & Oswald, J. C. (2021) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2020.12.005 · Cited by 3
Tait, M.-A., Costa, D. S. J., Campbell, R., Norman, R., Schug, S. A., & Rutherford, C. (2021) · JMIR Research Protocols · doi:10.2196/32327 · Cited by 3
Schecter, D., & Cyr, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-89918-9_7 · Cited by 3
Willow, J., Silva, A. I., Taning, C. N. T., Smagghe, G. J., & Veromann, E. (2022) · Pest Management Science · doi:10.1002/ps.7323 · Cited by 3
Cannabis and the Lung: No More Smoking Gun?
Ware, M. A. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201302-034ed · Cited by 3
Clarke, S. J., Butcher, B., McLachlan, A. J., Henson, J. D., Rutolo, D., Hall, S., & Vitetta, L. (2020) · doi:10.22541/au.159969847.76735495 · Cited by 3
Shah, D., Murhekar, S., Ward, M., Sagane, S., & Pahwani, A. (2025) · Cureus · doi:10.7759/cureus.87208 · Cited by 2
Tang, R., Gong, C.-Y., Liu, Y., Wang, Y.-B., & Zhou, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1656400 · Cited by 2
Cannabis and Cannabinoids (PDQ
Integrative, P. (2011) · Cited by 2
The medical use of cannabis in the Middle East
Shirah, B. H., Ahmed, M. M., & Saleh, R. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90036-2.00018-1 · Cited by 2
What Steps Should be Taken to Integrate Marijuana into Pain Regimens?
Wallace, M. S., & Furnish, T. J. (2015) · Pain Management · doi:10.2217/pmt.15.20 · Cited by 2
Should Medical Cannabis Administered by Inhalation Be Allowed for Hospitalized Patients?
Malcolm, B., Murphy, L. L., & (Con), M. W. (2018) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v71i3.2588 · Cited by 2
Wirksamkeit, Verträglichkeit und Sicherheit von medizinischem Cannabis
Hoch, E., Schneider, M., von Keller, R., Bonnet, U., Falkai, P., Hasan, A., Häuser, W., Hinz, B., Jakob, L., Kabisch, J., et al. (2018) · Springer eBooks · doi:10.1007/978-3-662-57291-7_4 · Cited by 2
Lee, J. B., Ghanem, G., Saadat, S., Yanuck, J., Yeung, B., Chakravarthy, B., Nelson, A. M., & Shah, S. (2021) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2021.5.52378 · Cited by 2
Korczeniewska, O. A., Eliav, E., & Benoliel, R. (2019) · Springer eBooks · doi:10.1007/978-3-319-72303-7_35 · Cited by 2
Complementary and Alternative Medicine
White, J. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00031-1 · Cited by 3
Korczeniewska, O. A., Eliav, E., & Benoliel, R. (2018) · Springer eBooks · doi:10.1007/978-3-319-28100-1_35-1 · Cited by 2
Do We Have Structure, Process and Outcomes to Support Cannabis as Supportive Therapy in Cancer?
Davis, M. P., Case, A. A., & Cyr, C. (2022) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/10499091221101561 · Cited by 2
Response to Stacey and Moller's Letter to the Editor
Wilsey, B. L., Marcotte, T. D., & Deutsch, R. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.07.003 · Cited by 2
Self-citationGrant, I. (2015) · JAMA · doi:10.1001/jama.2015.11429 · Cited by 2
Chou, R., Wagner, J., Ahmed, A. Y., Morasco, B. J., Kansagara, D. L., Selph, S., Holmes, R. S., & Fu, R. (2022) · doi:10.23970/ahrqepccannabissurveillance4 · Cited by 1
Social Justice and Medical Equity through Federal Legalization of Marijuana
Passley, T. M., Purcell, J. M., Torres, G., & Leheste, J. R. (2023) · Medical Research Archives · doi:10.18103/mra.v11i3.3697 · Cited by 1
Marijuana Use in a Nationwide Survey of Burn Survivors
Reyes, A. M., Ramsey, W. A., O’Neil, C. F., Cobler-Lichter, M. D., Ishii, M., Satahoo, S. S., Kaufman, J. I., Pizano, L. R., Koru‐Sengul, T., Szapocznik, J., et al. (2025) · Journal of Burn Care & Research · doi:10.1093/jbcr/iraf064 · Cited by 1
Insights into neuropathic pain: From disease models to therapeutic interventions
Nasır, A., Khan, T., Anam, A., Asad, M., Bakhtawar, H., & Bai, Q. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106878 · Cited by 1
Roundoc Rx: Nutritional and Botanical Approaches for Peripheral Neuropathy
ROUNTREE, R. L. (2015) · Alternative and Complementary Therapies · doi:10.1089/act.2015.29007.rr · Cited by 1
OP-ED Medicinal Cannabis and Painful Sensory Neuropathy
Md, I. G. (2013) · Cited by 1
The Ecology of Wild Cannabis sativa
Small, E. (2016) · CRC Press eBooks · doi:10.1201/9781315367583-12 · Cited by 1
Cannabis Chemistry: Cannabinoids in Cannabis, Humans, and Other Species
Small, E. (2016) · CRC Press eBooks · doi:10.1201/9781315367583-20 · Cited by 1
Appendix B: Quality Research, Evidence of Effectiveness of Medical Cannabis
(2018) · Journal of Nursing Regulation · doi:10.1016/s2155-8256(18)30099-1 · Cited by 1
Pharmacokinetics and Cognitive Side Effcets of Cannabidiol In Adult Patients
Mote, M. A. N., Bhise, M. P. B., Chavan, M. R. D., Patil, M. P. P., & Kengar, M. D. (2022) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-7676 · Cited by 1
Batham, M., Mirghasemi, S., Ojha, M., & Rahman, M. A. (2023) · Contributions to economics · doi:10.1007/978-981-99-4902-1_2 · Cited by 1
Banbury, S. A., Chandler, C., Erridge, S., Olvera, F. J. D. R., Turner, J. J., & Lusher, J. M. (2024) · Psychoactives · doi:10.3390/psychoactives3030024 · Cited by 1
Sexton, M., Glodosky, N. C., Cleveland, M. J., Cuttler, C., Lee, E., Polston, G. R., Furnish, T. J., Lerman, I. R., Schuster, N. M., & Wallace, M. S. (2025) · Pain Medicine · doi:10.1093/pm/pnaf113 · Cited by 1
McDonagh, M. S., Wagner, J., Ahmed, A. Y., Morasco, B. J., Kansagara, D. L., & Chou, R. (2021) · doi:10.23970/ahrqepccerplantpain3 · Cited by 1
Cannabinoids and Pain: Clinical Evidence
MacCallum, C. A., Eadie, L., & Narouze, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_25 · Cited by 1
Canavero, S., & Bonicalzi, V. (2018) · Springer eBooks · doi:10.1007/978-3-319-56765-5_17 · Cited by 1
Chou, R., Wagner, J., Ahmed, A. Y., Morasco, B. J., Kansagara, D. L., & Selph, S. (2022) · doi:10.23970/ahrqepccannabissurveillance3 · Cited by 1
Ethics of Pain Measurement and Management From the Editor Ethical Perspectives on Pain
Kumar, B. P., Berger, J. M., & Vadivelu, N. (2013)
A growing trend : policy diffusion of medical marijuana laws in the American states
Carrillo, D. E. (2013) · CSUN ScholarWorks (California State University, Northridge)
The Yin and Yang of clinical decision making before prescribing medical marijuana
Cirone, S., Dubin, R. E., Kahan, M., & Montgomery, L. S. (2014)
Cannabinoids and Cannabis Based Medicines in the Treatment of Chronic Pain: A Review
Lowe, H., Watson, C. T., & Smith, K. (2017) · West Indian Medical Journal · doi:10.7727/wimj.2016.513
Beck, T. A. (2017) · DukeSpace (Duke University)
Beaulieu, P., Boulanger, A., Desroches, J., & Clark, A. J. (2016)
Mina tratatzeko estrategia farmakologiko berriak: kannabinoideak
Aostri, E., Pineda, J., & Mendiguren, A. (2017) · Osagaiz osasun-zientzien aldizkaria · doi:10.26876/osagaiz.2.2017.91
Medisch gebruik van cannabis en zijn psychoactieve werking: een paradox?
Bawin, F. (2018) · Verslaving · doi:10.1007/s12501-018-0155-0
Cannabis medicinal: una guía para enfermeras
Pettinato, M. (2018) · Nursing (Ed española) · doi:10.1016/j.nursi.2018.03.010
Neurological Effects of Cannabis Use
Theriault, B. M. (2018) · American Journal of Psychiatry Residents Journal · doi:10.1176/appi.ajp-rj.2018.130606
Factors Affecting the Population’s Opinions Regarding Cannabis Treatment for Chronic Pain Patients
Grinberg, K. (2018) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2018.06.001295
Silverstone, P. H. (2018) · Advances in Social Sciences Research Journal · doi:10.14738/assrj.512.5864
Cannabis and Medicinal Properties.
Madras, B. K. (2016) · PubMed
Piomelli, D. (2019) · Cannabis and Cannabinoid Research · doi:10.1089/can.2019.29013.dpi
Maher, D. P., Shah, B. J., & Vorobeychik, Y. (2019) · Springer eBooks · doi:10.1007/978-3-030-27447-4_19 · Cited by 1
Can cannabinoids still play a role as pain medications?
Pittelkow, T. P., Pawar, N., & Hagedorn, J. M. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1946515
Kitzman, J., & Woodbury, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-75373-3_8
Cannabis: A vexing foe or a perioperative acquaintance?
Merrill, D., Goel, S., & Thakrar, S. P. (2021) · Perioperative Care and Operating Room Management · doi:10.1016/j.pcorm.2021.100205
Adansonia digitata and its use in neuropathic pain: Prostaglandins and beyond
Oyewole, A. L., Alli-Oluwafuyi, A. O., Nafiu, A. B., & Imam, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820237-1.00030-2
Portenoy, R. K., Ahmed, E., & Patel, M. (2021) · doi:10.1093/med/9780198821328.003.0042
da Silveira, B. V. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2021.tde-22032022-152455
Appendix C: References (Part I)
(2018) · Journal of Nursing Regulation · doi:10.1016/s2155-8256(18)30100-5
Cornett, E. M., Moreci, R. A., Korneeva, N. L., & Jones, M. R. (2019) · Springer eBooks · doi:10.1007/978-3-319-96125-5_3
McDonagh, M. S., Wagner, J., Ahmed, A. Y., Morasco, B. J., Kansagara, D. L., & Chou, R. (2022) · doi:10.23970/ahrqepccannabissurveillance2
Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1
Singh, R. B. H., VanderPluym, J. H., Hasan, B., Farah, M. H., Viola, K. E., Saadi, S. M., Shah, S. H., Nayfeh, T., Prokop, L. J., Murad, M., et al. (2022) · doi:10.23970/ahrqepcmigrainesurveillance1 · Cited by 1
Rometsch, C., Ott, S. J., Wietek, T. F., Jurjut, A.-M., Schlisio, B., Zipfel, S., Stengel, A., & Herrmann‐Werner, A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1033020 · Cited by 1
Sabet, K. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91497-0.00255-1
Antihyperalgesic effect of joint mobilization requires Cav3.2 calcium channels
Martins, D. F., Sorrentino, V., Mazzardo‐Martins, L., Reed, W. R., Santos, A. R. S., Gadotti, V. M., & Zamponi, G. W. (2023) · Molecular Brain · doi:10.1186/s13041-023-01049-3
The Analgesic Effects of Cannabis
Ross, I. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-35155-6_7
Potential Medical Benefits of Cannabis sativa and Its Controversies
Hisam, A. H. S., Rasli, N., Razak, N. F. A., Ajmer, A. S. N. A., Daniel, J. D., Enshasy, H. A. E., Tan, W., & Tong, W. Y. (2023) · Malaysian Journal of Medicine and Health Sciences · doi:10.47836/mjmhs.19.s9.43
Fitocanabidióides como adjuvante ao tratamento de processos álgicos: uma revisão sistemática
Marques, M. H. V. P., de Alencar, Y. C. G., da Nóbrega, D. A. B., Xavier, F. W., Nogueira, L. V. L., & de Sousa, M. N. A. (2022) · Revista Brasileira de Filosofia e História · doi:10.18378/rbfh.v11i1.9546
Cannabidiol (CBD) no tratamento de dor crônica
Nascimento, G. D. S., Cândido, I. F., Vieira, M. V. C., & Silva, P. H. S. (2024) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2024v6n5p1827-1837
The Elusive Truth of Cannabinoids for Rheumatic Pain
Clarke, H. A., Miles, S. J., Peer, M., & Fitzcharles, M. (2024) · Current Rheumatology Reports · doi:10.1007/s11926-024-01162-9
Clinical uses of cannabis and Catha edulis products
Ezzat, S. M., Abdel-Baki, P. M., Ibrahim, R. M., Elezz, D. A., Abdelaziz, M., & Salem, M. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95927-8.00028-1
Use of Cannabinoids Without Psychotropic Effect on Treatment of Neurological Disorders
Israel, R., & la Cruz-Torres, E. D. (2024) · Springer eBooks · doi:10.1007/978-3-031-63677-6_8
Meta-Analysis of Herbal Cannabis Therapy for Chronic Pain
Seneca, M. (2014) · University of North Florida Digital Commons (University of North Florida)
EFFICACY AND SAFETY OF CANNABINOIDS IN PATIENTS WITH NEUROPATHIC PAIN (LITERATURE REVIEW)
Хайтович, М. В., & Місюра, О. М. (2025) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.1.2025.19 · Cited by 1
Aplicaciones terapéuticas de Cannabis sativa en neuropatías: Revisión sistemática en América Latina
Sierra, E., Lopez, L. M., Maldonado, E. D. P., Johnson, D. Y. C., Luna, Á. D. L., Peralta, M. G. H., & Ruiz, F. V. B. (2025) · Portal de la Ciencia · doi:10.5377/pc.v1i20.20414
What do we know about marijuana’s medical benefits? Two experts explain the evidence
Kinsey, S. G., & Ramesh, D. (2016) · doi:10.64628/aai.dfmcs9y3u
Bienfaits et risques du cannabis : ce que dit la science
Kinsey, S. G., & Ramesh, D. (2017) · doi:10.64628/aak.measdvdn5
Delta-9-tetrahydrocannabinol and Cannabidiol for Pain: Preclinical and Clinical Models
Harris, H. M., Moore, C. F., Jenkins, B. W., Bedillion, M. F., Weerts, E. M., & Arout, C. A. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2025_604 · Cited by 1
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Complex Regional Pain Syndrome
Evans, L., Erridge, S., Varadpande, M., Aggarwal, A., Cowley, I., Clarke, E., McLachlan, K., Coomber, R., Rucker, J., Platt, M. W., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.70823
Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines
Vitetta, L., Henson, J. D., Hayes, E., Rutolo, D., & Hall, S. (2025) · Pharmaceuticals · doi:10.3390/ph18091385 · Cited by 1
Additional file 1 of A bibliometric analysis of the cannabis and cannabinoid research literature
Ng, J. Y., & Chang, N. (2022) · Figshare · doi:10.6084/m9.figshare.19862814
Metadata
- Authors
- Wilsey, B., Marcotte, T., Deutsch, R., Gouaux, B., Sakai, S., & Donaghe, H.
- Affiliations
- VA Northern California Health Care System (US)
- University of California San Diego (US)
- University of California, Davis (US)
- Venue
- The Journal of Pain
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 14
- Issue
- 2
- Pages
- 136-148
- ISSN
- 1526-5900 (ISSN-L)
- PMC
- PMC3566631
- OpenAlex
- W2167149788
- Cited by
- 314
- References
- 64
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 14 · 2023: 24 · 2022: 27 · 2021: 36 · 2020: 21 · 2019: 27 · 2018: 37 · 2017: 25 · 2016: 26 · 2015: 20 · 2014: 16 · 2013: 11
- FWCI
- 11.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Pain (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Johns Hopkins University
- National Institutes of Health
- University of California, Davis
- National Institute on Drug Abuse (R01DA030424)
- National Center for Research Resources (UL1RR024146)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- vaporized cannabis, neuropathic pain, delta-9-tetrahydrocannabinol, analgesic efficacy, treatment-resistant pain, neuropsychological performance, number needed to treat
- MeSH terms
- Administration, Inhalation, Adult, Affect, Cannabis, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Hyperalgesia, Male, Phytotherapy, Middle Aged, Neuralgia, Neuropsychological Tests, Pain Measurement, Socioeconomic Factors, Dronabinol, Volatilization, Linear Models, Treatment Outcome, Pain Threshold, Patient Selection, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
